Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | PARL | Q9H300 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31452871 | 1.00 | HTR6 (0.55) | HTR6ALDH1A1TDP1CA1CA2 | |
| SCHEMBL31452872 | 1.00 | HTR6 (0.55) | HTR6ALDH1A1TDP1CA1CA2 | |
| Magnesium SCHEMBL30610988 | 0.97 | HTR6 (0.52) | HTR6ALDH1A1TDP1CA1CA2 | |
| Potassium SCHEMBL29613228 | 0.97 | HTR6 (0.52) | HTR6ALDH1A1TDP1CA1CA2 | |
| SCHEMBL31452875 | 0.97 | HTR6 (0.52) | HTR6ALDH1A1TDP1CA1CA2 | |
| SCHEMBL29121435 | 0.97 | HTR6 (0.52) | HTR6ALDH1A1TDP1CA1CA2 | |
| Calcium SCHEMBL31452873 | 0.97 | HTR6 (0.52) | HTR6ALDH1A1TDP1CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL31603815 | 0.97 | HTR6 (0.52) | HTR6ALDH1A1TDP1CA1CA2 | |
| SCHEMBL28345961 | 0.95 | HTR6 (0.50) | HTR6ALDH1A1TDP1CA1CA2 | |
| Sulfuric Acid SCHEMBL25411375 | 0.90 | HTR6 (0.46) | HTR6ALDH1A1TDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865932-B | Preparation method of benzothiophene sulfone compound with medicinal and fluorescent activity | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026100731-A1 | COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, OPTICAL MATERIAL, AND LENS | 三井化学株式会社 | 2026-05-15 | — | — | WO | claimed |
| US-12540140-B2 | Process for the preparation of remimazolam | FRESENIUS KABI ONCOLOGY LTD. (IN) | 2026-02-03 | — | — | US | claimed |
| US-20250263414-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF REMIMAZOLAM | FRESENIUS KABI ONCOLOGY LIMITED (IN) | 2025-08-21 | — | — | US | claimed |
| CN-119320567-B | Asphalt solid phase composition for coating, modified asphalt coated natural graphite anode material, preparation thereof and lithium ion battery | 五矿勘查开发有限公司 | 2025-03-07 | — | — | CN | claimed |
| EP-4504731-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF REMIMAZOLAM | Fresenius Kabi Oncology Ltd (IN) | 2025-02-12 | — | — | EP | claimed |
| CN-119320567-A | Asphalt solid phase composition for coating, modified asphalt coated natural graphite anode material, preparation thereof and lithium ion battery | 五矿勘查开发有限公司 | 2025-01-17 | — | — | CN | claimed |
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | WUYAN PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD (CN) | 2024-11-07 | — | — | US | claimed |
| CN-118638274-A | Polyvinyl alcohol microsphere and preparation method and application thereof | 湖南埃普特医疗器械有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-118359931-A | Flow line master batch applicable to polycarbonate, preparation method and application | 万华化学集团股份有限公司 | 2024-07-19 | — | — | CN | claimed |
| WO-2000029362-A1 | 1,4-DIARYL-2-FLUORO-1-BUTEN-3-OL COMPOUNDS AND THEIR USE IN THE PREPARATION OF 1,4-DIARYL-2-FLUORO-1,3-BUTADIENE AND 1,4-DIARYL-2-FLUORO-2-BUTENE COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 2000-05-25 | — | — | WO | claimed |
| EP-0955998-A2 | MICROPARTICLES CONTAINING ACTIVE SUBSTANCES, AGENTS CONTAINING THE SAME, THEIR USE IN ULTRASOUND-CONTROLLED RELEASING OF ACTIVE SUBSTANCES AS WELL AS THE METHOD FOR THEIR PRODUCTION | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-11-17 | — | — | EP | claimed |
| WO-1998020856-A2 | MICROPARTICLES CONTAINING ACTIVE SUBSTANCES, AGENTS CONTAINING THE SAME, THEIR USE IN ULTRASOUND-CONTROLLED RELEASING OF ACTIVE SUBSTANCES AS WELL AS THE METHOD FOR THEIR PRODUCTION | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-05-22 | — | — | WO | claimed |
| EP-0372009-A4 | CONDUCTIVE POLYMER MATERIALS AND METHOD OF PRODUCING SAME | — | 1990-09-05 | — | — | EP | claimed |
| EP-0372009-A1 | CONDUCTIVE POLYMER MATERIALS AND METHOD OF PRODUCING SAME | LOCKHEED CORPORATION (US) | 1990-06-13 | — | — | EP | claimed |
| WO-1989007631-A1 | CONDUCTIVE POLYMER MATERIALS AND METHOD OF PRODUCING SAME | LOCKHEED CORPORATION (US) | 1989-08-24 | — | — | WO | claimed |
| US-4851487-A | Conductive polymer materials and method of producing same | LOCKHEED CORPORATION (US) | 1989-07-25 | — | — | US | claimed |
| EP-0225974-A2 | Process for producing lactams with 8 to 15 carbon atoms from their corresponding oximes | HÜLS AKTIENGESELLSCHAFT (DE) | 1987-06-24 | — | — | EP | claimed |
| EP-0061761-A1 | A method for preparing a mononucleotide-3'-phosphodiester-based substrate | Baker Instruments Corporation (US) | 1982-10-06 | — | — | EP | claimed |
| US-4115058-A | BLEACHES, DETERGENTS | FMC CORPORATION (US) | 1978-09-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | ANTXR2, AKR7A2, ACR | HTR6 3877/4885ALDH1A1 1295/4885TDP1 3635/4885 |
| US-12540140-B2 | Process for the preparation of remimazolam | SCN2B, HCN3, KCNH1 | HTR6 1254/4885ALDH1A1 1255/4885TDP1 4519/4885 |
| US-20250263414-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF REMIMAZOLAM | CYP4F3, HRH4, HRH3 | HTR6 518/4885ALDH1A1 873/4885TDP1 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.